Skip to main content
    A

    AstraZeneca PLC (AZN)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $184.45
    +0.07 (+0.04%)

    Market Cap: $286.07B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    AstraZeneca PLC (AZN) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to AstraZeneca are Amgen (AMGN), Novartis AG ADR (NVS) and Novo Nordisk A/S (NVO). AstraZeneca trades at 22.5x earnings, against a median of 19.9x for the 9 of these companies with a P/E. By market cap, AstraZeneca ranks 6th of the 13 companies on this page; Eli Lilly and Company (LLY) is the largest at $1.29T.

    Peer Comparison

    AZN's ROIC of 14.9% is above the peer median of 13.5%, and its revenue growth of 6.7% is above the median of 6.3%. Its dividend yield is below the peer median of 2.67%.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    AstraZeneca (AZN)$286.07B22.5x4.6x17.7%14.9%6.7%1.16%
    Amgen Inc (AMGN)$251.89B19.9x6.4x24.1%17.0%8.5%2.18%
    Novartis AG ADR (NVS)$303.12B18.7x5.4x17.5%13.5%4.7%2.98%
    Novo Nordisk A/S (NVO)$183.52BN/A3.6x33.9%34.1%5.6%4.32%
    GSK plc (GSK)$101.13B10.5x2.3x13.0%N/A4.0%3.58%
    Pfizer Inc (PFE)$164.67B9.5x2.6x6.3%2.7%-0.4%5.96%
    Bristol-Myers Squibb Company (BMY)$129.66B10.1x2.6x18.5%13.9%6.9%4.00%
    Merck & Company Inc (MRK)$364.26B46.3x5.3x3.6%3.1%4.7%2.35%
    AbbVie Inc (ABBV)$521.50B23.0x7.9x15.7%16.4%10.3%2.35%
    Gilead Sciences Inc (GILD)$208.48BN/A6.7x-12.5%-3.9%6.8%1.96%
    Sanofi ADR (SNY)$116.15BN/A2.0x8.2%7.6%15.7%5.01%
    Johnson & Johnson (JNJ)$687.89B26.6x6.9x16.2%12.8%5.9%1.90%
    Eli Lilly and Company (LLY)$1.29T44.9x14.8x31.9%30.7%38.6%0.48%
    Peer median$230.18B19.9x5.4x15.9%13.5%6.3%2.67%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to AstraZeneca, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - General.

    CompanyAboutPeers
    Amgen Inc (AMGN)
    Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
    AMGN competitors
    Novartis AG ADR (NVS)
    Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
    NVS competitors
    Novo Nordisk A/S (NVO)
    Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally.
    NVO competitors
    GSK plc (GSK)
    GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines...
    GSK competitors
    Pfizer Inc (PFE)
    Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City.
    PFE competitors
    Bristol-Myers Squibb Company (BMY)
    Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City.
    BMY competitors
    Merck & Company Inc (MRK)
    Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey.
    MRK competitors
    AbbVie Inc (ABBV)
    AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
    ABBV competitors
    Gilead Sciences Inc (GILD)
    Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California...
    GILD competitors
    Sanofi ADR (SNY)
    Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe...
    SNY competitors
    Johnson & Johnson (JNJ)
    Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
    JNJ competitors
    Eli Lilly and Company (LLY)
    Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.
    LLY competitors

    Frequently Asked Questions About AZN

    Who are AstraZeneca's main competitors?

    The companies most similar to AstraZeneca include Amgen (AMGN), Novartis AG ADR (NVS), Novo Nordisk A/S (NVO), GSK (GSK) and Pfizer (PFE), listed from the closest match.

    Who is AstraZeneca's biggest competitor?

    Eli Lilly and Company (LLY) is the largest of the similar companies at $1.29T; Amgen (AMGN) is the closest match by business profile, size, sector and industry.

    How does AZN stock compare with its competitors?

    AZN's P/E is 22.5x against a peer median of 19.9x; its P/S is 4.6x against a peer median of 5.4x; its net margin is 17.7% against a peer median of 15.9%.

    Which of AstraZeneca's competitors pays a higher dividend?

    AstraZeneca has a forward dividend yield of 1.16%. Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb Company (BMY), GSK (GSK), Novartis AG ADR (NVS), Merck & Company (MRK), AbbVie (ABBV), Amgen (AMGN), Gilead Sciences (GILD) and Johnson & Johnson (JNJ) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.

    Is AstraZeneca bigger than its competitors?

    No. AstraZeneca is 6th by market cap among the 13 companies on this page; the largest is Eli Lilly and Company (LLY) at $1.29T.